Danes urge centralisation to combat pancreatic cancer
This article was originally published in Clinica
Operations for the treatment of pancreatic cancer in Denmark are of a considerably lower standard than in countries with comparable general healthcare standards and result in too may deaths. This is the view expressed this week in an article on pancreato-duodenectomy in Denmark from 1996-2001, and published in the doctors' weekly journal, Ugeskrift for Laeger.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.